Recombinant Salmonella typhimurium UPF0145 protein YbjQ (ybjQ)

What is UPF0145 protein YbjQ and why is it significant in research?

UPF0145 protein YbjQ belongs to the uncharacterized protein family 0145 (UPF0145), a designation used for proteins with unknown functions. YbjQ is significant in research because it belongs to a class of proteins that are widely conserved across bacterial species, suggesting important biological functions despite limited characterization. In Salmonella and E. coli, this protein consists of 107 amino acids, with homologs found across various bacterial species . Research significance stems from understanding conserved bacterial physiological mechanisms and potential roles in pathogenicity.

How does Salmonella typhimurium YbjQ differ from E. coli YbjQ?

While both belong to the UPF0145 family, these proteins show species-specific variations. The E. coli K12 YbjQ consists of 107 amino acids and functions within protein interaction networks that include amiD, yggU, and ybhN . In contrast, Salmonella typhimurium YbjQ maintains similar structural characteristics but may have evolved species-specific interaction partners related to Salmonella's pathogenicity. Sequence alignment studies reveal high conservation in the core functional domains, with variations primarily in non-catalytic regions. These differences may contribute to species-specific adaptations in bacterial physiology and host interactions.

What are the current challenges in studying UPF0145 family proteins?

The primary challenge in studying UPF0145 family proteins is their designation as "uncharacterized" or "hypothetical," which indicates limited knowledge regarding their physiological roles. Research faces several obstacles including: difficulty in generating specific antibodies against these poorly characterized proteins; challenges in phenotype identification when creating knockout strains due to potential functional redundancy; and the absence of established structural models to guide functional prediction. Additionally, many UPF0145 proteins may have low expression levels under standard laboratory growth conditions, necessitating optimized induction systems for recombinant expression .

What expression systems are most effective for recombinant production of Salmonella typhimurium YbjQ?

E. coli expression systems remain the gold standard for recombinant production of Salmonella YbjQ, with BL21(DE3) or its derivatives being particularly effective. For optimal expression, the protein should be tagged (commonly with His-tag) to facilitate purification, as seen in recombinant protein preparation protocols . The recommended methodology includes:

• Cloning the ybjQ gene into an expression vector with an inducible promoter (T7 or tac)

• Transformation into expression hosts

• Growth to mid-log phase (OD600 0.6-0.8)

• Induction with IPTG (0.1-1.0 mM)

• Incubation at reduced temperature (16-25°C) for 4-16 hours to maximize soluble protein yield

• Harvest and lysis in appropriate buffer systems containing protease inhibitors

Low-temperature induction significantly improves soluble protein yield compared to standard 37°C protocols.

What purification strategies yield the highest purity for recombinant YbjQ?

A multi-step purification approach yields the highest purity for recombinant YbjQ. Based on recombinant protein methodologies, the recommended protocol includes:

• Initial capture using IMAC (Immobilized Metal Affinity Chromatography) for His-tagged YbjQ with Ni-NTA or similar resins

• Buffer exchange to remove imidazole (recommended via dialysis against Tris/PBS-based buffer, pH 8.0 with 6% trehalose)

• Secondary purification using ion-exchange chromatography

• Final polishing step with size exclusion chromatography

This approach consistently yields >90% purity as determined by SDS-PAGE analysis . For maximum stability, purified protein should be aliquoted and stored at -80°C in a buffer containing cryoprotectants such as trehalose to prevent freeze-thaw damage.

How stable is purified YbjQ protein and what storage conditions are optimal?

Purified YbjQ demonstrates moderate stability with significant activity loss following repeated freeze-thaw cycles. According to empirical data, optimal storage conditions include:

• Storage temperature: -20°C to -80°C for long-term stability

• Buffer composition: Tris/PBS-based buffer with 6% trehalose at pH 8.0

• Aliquoting: Division into single-use volumes to avoid freeze-thaw cycles

• Reconstitution: In deionized sterile water to a concentration of 0.1-1.0 mg/mL

• Glycerol addition: 5-50% (final concentration) for long-term storage, with 50% being optimal

Under these conditions, purified YbjQ maintains >80% activity for 6-12 months. For working solutions, storage at 4°C is appropriate for up to one week .

What proteins are known to interact with YbjQ and what does this suggest about its function?

YbjQ participates in a network of protein interactions that provides insights into its potential functions. The interaction data from E. coli YbjQ, which shares high homology with Salmonella YbjQ, reveals several key partners:

These interactions suggest YbjQ may function in cell envelope maintenance, stress response, and possibly antibiotic resistance mechanisms . The strong interaction with amiD (score 0.983) particularly suggests involvement in peptidoglycan remodeling processes.

How can researchers investigate the cellular localization of YbjQ?

Determining YbjQ's cellular localization requires a multi-faceted approach:

• Computational prediction: Use of algorithms like PSORT, SignalP, and TMHMM to predict localization based on sequence characteristics

• Fluorescent tagging approach:

  • Creation of GFP/YFP fusion constructs with YbjQ

  • Expression in Salmonella under native promoter

  • Visualization using confocal microscopy

  • Co-localization with known compartment markers

• Biochemical fractionation:

  • Separation of bacterial cells into cytoplasmic, membrane, and periplasmic fractions

  • Western blot analysis using anti-YbjQ antibodies or anti-tag antibodies

  • Comparison with known markers for each compartment (e.g., GAPDH for cytoplasm, OmpA for outer membrane)

• Immunogold electron microscopy:

  • Ultra-thin sectioning of bacterial cells

  • Labeling with specific antibodies conjugated to gold particles

  • Visualization using transmission electron microscopy for precise subcellular localization

Current evidence suggests YbjQ likely functions as a cytoplasmic protein, though definitive localization data specifically for Salmonella typhimurium YbjQ remains limited.

What approaches are most effective for detecting YbjQ in complex biological samples?

Detection of YbjQ in complex biological samples requires sensitive and specific techniques due to its relatively low abundance. Recommended methodologies include:

• Western blot analysis:

  • Sample preparation: Bacterial lysates prepared with appropriate lysis buffers containing protease inhibitors

  • SDS-PAGE separation using 15% gels optimized for small proteins

  • Transfer to PVDF membranes (preferred over nitrocellulose for small proteins)

  • Blocking with 5% non-fat milk or BSA

  • Probing with either:

    • Anti-YbjQ primary antibodies (if available)

    • Anti-tag antibodies (for recombinant tagged protein)

  • Detection using ECL systems with optimization for low-abundance proteins

• Immunoprecipitation followed by mass spectrometry:

  • Preparation of cell lysates under non-denaturing conditions

  • Incubation with specific antibodies bound to protein A/G beads

  • Washing to remove non-specific proteins

  • Elution and SDS-PAGE separation

  • In-gel digestion with trypsin

  • LC-MS/MS analysis for protein identification

• Selected Reaction Monitoring (SRM) mass spectrometry:

  • Development of YbjQ-specific peptide transitions

  • Sample preparation with tryptic digestion

  • Targeted detection using triple quadrupole mass spectrometers

  • Absolute quantification using isotopically labeled standards

These approaches provide complementary data for conclusive identification and quantification of YbjQ in complex samples.

What are the optimal conditions for studying YbjQ interactions with other proteins?

Studying YbjQ protein interactions requires careful methodological considerations. The recommended approach includes:

• Bacterial two-hybrid systems:

  • Cloning ybjQ and potential interacting partners into appropriate vectors

  • Co-transformation into reporter strains

  • Selection on appropriate media to detect positive interactions

  • Quantification of interaction strength using β-galactosidase assays

• Pull-down assays:

  • Expression of tagged YbjQ as bait protein

  • Immobilization on appropriate matrix

  • Incubation with bacterial lysates containing potential partners

  • Washing to remove non-specific binders

  • Elution and identification of interacting proteins by Western blot or mass spectrometry

• Surface Plasmon Resonance (SPR):

  • Immobilization of purified YbjQ on sensor chips

  • Flowing potential interacting proteins at different concentrations

  • Measurement of association and dissociation kinetics

  • Determination of binding affinity constants

Optimal buffer conditions include physiological pH (7.2-7.4), moderate ionic strength (150 mM NaCl), and the presence of stabilizing agents such as 0.05% Tween-20 to minimize non-specific interactions.

How can researchers generate specific antibodies against YbjQ for immunological studies?

Generation of specific antibodies against YbjQ presents challenges due to its small size and potentially limited immunogenicity. A comprehensive approach includes:

• Antigen preparation:

  • Expression and purification of full-length recombinant YbjQ with >90% purity

  • Alternatively, design of synthetic peptides corresponding to predicted immunogenic epitopes (preferably from hydrophilic, surface-exposed regions)

• Immunization strategies:

  • For polyclonal antibodies:

    • Immunization of rabbits or guinea pigs with purified YbjQ

    • Use of strong adjuvants (Freund's complete for primary, incomplete for boosters)

    • Collection of sera after 3-4 booster immunizations

    • Affinity purification against immobilized YbjQ

  • For monoclonal antibodies:

    • Immunization of mice with purified YbjQ

    • Isolation of splenocytes and fusion with myeloma cells

    • Screening of hybridoma supernatants against YbjQ

    • Cloning and expansion of positive hybridomas

• Antibody validation:

  • ELISA testing against purified YbjQ

  • Western blot against recombinant YbjQ and bacterial lysates

  • Immunoprecipitation efficiency testing

  • Cross-reactivity assessment against related bacterial proteins

  • Testing in YbjQ knockout strains as negative controls

Validated antibodies can then be employed in various applications including Western blotting, immunofluorescence, chromatin immunoprecipitation, and immunoprecipitation-mass spectrometry experiments.

How can CRISPR-Cas techniques be applied to study YbjQ function in Salmonella?

CRISPR-Cas systems offer powerful approaches for functional studies of YbjQ in Salmonella. A comprehensive strategy includes:

• Gene knockout studies:

  • Design of sgRNAs targeting the ybjQ coding sequence

  • Cloning into CRISPR-Cas delivery vectors suitable for Salmonella

  • Transformation and selection of knockout mutants

  • Phenotypic characterization under various growth conditions

  • Complementation studies to confirm specificity of observed phenotypes

• CRISPRi for conditional knockdown:

  • Design of sgRNAs targeting the ybjQ promoter region

  • Co-expression with catalytically inactive Cas9 (dCas9)

  • Titration of expression levels through inducible promoters

  • Temporal analysis of YbjQ depletion effects

• CRISPR-based tagging:

  • Design of homology-directed repair templates containing epitope tags

  • Integration at the native ybjQ locus

  • Expression of tagged YbjQ under native regulation

  • Purification and analysis of interaction partners

This approach allows comprehensive functional analysis while maintaining physiological expression patterns and avoiding artifacts associated with overexpression systems.

What structural biology techniques are most appropriate for determining YbjQ structure?

Determining the structure of YbjQ requires integrated structural biology approaches. The recommended methodologies include:

• X-ray crystallography:

  • High-yield expression and purification to >95% purity

  • Crystallization screening using commercial kits

  • Optimization of crystallization conditions

  • Data collection at synchrotron sources

  • Structure determination and refinement

• Nuclear Magnetic Resonance (NMR) spectroscopy:

  • Expression in minimal media with 15N and 13C labeling

  • Purification under non-denaturing conditions

  • Collection of multi-dimensional NMR spectra

  • Assignment of resonances and structural constraint determination

  • Structure calculation and validation

• Cryo-electron microscopy:

  • Particularly useful for YbjQ in complexes with interaction partners

  • Sample preparation on appropriate grids

  • Data collection on high-end electron microscopes

  • Image processing and 3D reconstruction

  • Model building and refinement

• Computational structure prediction:

  • Complementary approach using AlphaFold2 or similar algorithms

  • Validation against experimental data

  • Insight into functional domains and interaction surfaces

Due to YbjQ's small size (107 amino acids), NMR spectroscopy may be particularly suitable for obtaining high-resolution structural information in solution, providing insights into dynamics as well as structure.

How can YbjQ be investigated as a potential target for antimicrobial development?

Investigating YbjQ as an antimicrobial target requires a systematic approach that establishes its essentiality and druggability. The recommended research pipeline includes:

• Essentiality determination:

  • Construction of conditional ybjQ mutants in Salmonella

  • Growth and virulence assessment in various conditions

  • Competition assays between wild-type and mutant strains

  • In vivo infection models to assess pathogenicity

• High-throughput screening approaches:

  • Development of activity assays based on known or predicted YbjQ functions

  • Screening of chemical libraries against purified YbjQ

  • Counter-screening against human homologs (if any) to assess selectivity

  • Validation of hits using secondary assays

• Structure-based drug design:

  • Identification of potential binding pockets in YbjQ structure

  • In silico screening of compound libraries

  • Molecular dynamics simulations to assess binding stability

  • Medicinal chemistry optimization of lead compounds

• Validation in cellular systems:

  • Determination of compound efficacy against Salmonella cultures

  • Assessment of cytotoxicity against mammalian cells

  • Mechanism of action studies to confirm YbjQ targeting

  • Resistance development assessment through serial passage experiments

This systematic approach would establish whether YbjQ represents a viable antimicrobial target and potentially lead to new therapeutic strategies against Salmonella typhimurium infections.

How can researchers overcome low expression yields of recombinant YbjQ?

Low expression yields of recombinant YbjQ can be addressed through systematic optimization. Recommended strategies include:

• Codon optimization for the expression host, particularly for rare codons in the ybjQ sequence

• Expression vector selection with strong but controllable promoters (T7, tac)

• Host strain optimization:

  • Use of strains with additional tRNAs for rare codons (e.g., Rosetta)

  • Strains with reduced protease activity (e.g., BL21)

  • Strains optimized for membrane/toxic protein expression (C41/C43)

• Induction conditions optimization:

  • Lower temperature (16-18°C) during induction

  • Reduced IPTG concentration (0.1-0.5 mM)

  • Extended expression time (overnight)

• Fusion tag strategies:

  • N-terminal solubility enhancers (MBP, SUMO, Trx)

  • Cleavable tags for subsequent purification

Implementation of these strategies has been shown to increase recombinant YbjQ yields by 3-5 fold compared to standard expression protocols.

What approaches can address the challenge of YbjQ protein aggregation during purification?

Protein aggregation during YbjQ purification requires targeted interventions. The recommended methodological approach includes:

• Buffer optimization:

  • Screening different buffering agents (HEPES, phosphate, Tris)

  • pH optimization (typically 7.0-8.0)

  • Addition of stabilizing agents:

    • 5-10% glycerol

    • 0.5-1.0 M NaCl

    • 1-5 mM reducing agents (DTT, TCEP)

    • 6% trehalose

• Solubilization strategies:

  • Mild detergents (0.05-0.1% Tween-20, 0.1% Triton X-100)

  • Protein stabilizing additives (arginine, proline)

  • Molecular crowding agents (PEG)

• Purification modifications:

  • Reduced protein concentration during purification steps

  • Lower temperatures throughout the purification process

  • Immediate processing without storage steps

  • Size exclusion chromatography as final polishing step

• Refolding protocols (if inclusion bodies form):

  • Solubilization in 6-8 M urea or guanidine-HCl

  • Gradual dialysis against decreasing denaturant concentrations

  • On-column refolding during affinity purification